Literature DB >> 25715176

Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis.

Kyle M Coleman1, Johann E Gudjonsson2, Michael Stecher3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25715176     DOI： 10.1001/jamadermatol.2014.5391

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  9 in total

1.  IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis.

Authors:  Ankit Malik; Deepika Sharma; Qifan Zhu; Rajendra Karki; Clifford S Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2016-10-24       Impact factor: 14.808

Review 2.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 3.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 4.  Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.

Authors:  Gabriele Fenini; Emmanuel Contassot; Lars E French
Journal:  Front Pharmacol       Date:  2017-05-22       Impact factor: 5.810

Review 5.  Cell death-mediated cytokine release and its therapeutic implications.

Authors:  David E Place; Thirumala-Devi Kanneganti
Journal:  J Exp Med       Date:  2019-06-11       Impact factor: 14.307

Review 6.  IL-1 Family Cytokines in Inflammatory Dermatoses: Pathogenetic Role and Potential Therapeutic Implications.

Authors:  Helena Iznardo; Luís Puig
Journal:  Int J Mol Sci       Date:  2022-08-22       Impact factor: 6.208

Review 7.  HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins.

Authors:  Damien Bertheloot; Eicke Latz
Journal:  Cell Mol Immunol       Date:  2016-08-29       Impact factor: 11.530

8.  Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes.

Authors:  Jianghong Zhong; Tatjana Scholz; Anthony C Y Yau; Simon Guerard; Ulrike Hüffmeier; Harald Burkhardt; Rikard Holmdahl
Journal:  Sci Adv       Date:  2018-05-16       Impact factor: 14.136

Review 9.  Immunomodulatory aspects in the progression and treatment of oral malignancy.

Authors:  Nobuo Kondoh; Masako Mizuno-Kamiya; Naoki Umemura; Eiji Takayama; Harumi Kawaki; Kenji Mitsudo; Yasunori Muramatsu; Shinichiro Sumitomo
Journal:  Jpn Dent Sci Rev       Date:  2019-10-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.